Ovid Therapeutics Inc. (OVID)
USD 1.01
(-4.72%)
USD 1.01
(-4.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -45.78 Million | -55.22 Million | 118.61 Million | -51.58 Million | -51.09 Million | -45.55 Million |
| Net Income | -52.33 Million | -54.16 Million | 122.83 Million | -81.03 Million | -60.46 Million | -51.97 Million |
| Depreciation & Amortization | 1.59 Million | 1.38 Million | 237.07 Thousand | 306.84 Thousand | 255 Thousand | 141.73 Thousand |
| Deferred income taxes | -1.75 Billion | - | - | - | - | 4610.00 |
| Stock-based compensation | 7.28 Million | 6.55 Million | 5.05 Million | 7.52 Million | 5.2 Million | 7.06 Million |
| Change in working capital | 2.38 Million | -8.23 Million | -16.81 Million | 21.81 Million | 3.93 Million | -787.91 Thousand |
| Other non-cash items | 1.74 Billion | -764.93 Thousand | 7.3 Million | -199.4 Thousand | -29.63 Thousand | -1240.00 |
| Investing Cash Flow | -2.58 Million | -87.88 Million | -1.82 Million | 34.64 Million | -30.04 Million | -5.36 Million |
| Investments in PPE | -137.45 Thousand | -1.41 Million | -189.4 Thousand | -390.68 Thousand | -244.04 Thousand | -352.01 Thousand |
| Acquisitions | -10 Million | -2.5 Million | -1.63 Million | 263.44 Thousand | 186.88 Thousand | 318.14 Thousand |
| Investment purchases | -122.44 Million | -172.96 Million | -1.63 Billion | -9.96 Million | -34.79 Million | -50.01 Million |
| Sales/Maturities of investments | 120 Million | 90 Million | 1.63 Billion | 45 Million | 5 Million | 45 Million |
| Other Investing Activities | 10 Million | -1 Million | -5.4 Million | -263.44 Thousand | -186.88 Thousand | -318.14 Thousand |
| Financing Cash Flow | 30.53 Million | 180.65 Thousand | 904.08 Thousand | 47.07 Million | 86.53 Million | 286.14 Thousand |
| Debt repayment | -30 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 535.2 Thousand | 180.65 Million | 925.39 Thousand | 46.73 Million | 86.4 Million | 286.14 Thousand |
| Other Financing Activities | 30 Million | -180.47 Million | -21.31 Thousand | 341.03 Thousand | 131.89 Thousand | 286.14 Thousand |
| Accounts receivables | - | - | 141.76 Thousand | 989.38 Thousand | -531.04 Thousand | - |
| Accounts payables | 1.75 Million | -5.17 Million | 1.7 Million | 2.33 Million | -653.95 Thousand | 1.64 Million |
| Inventory | - | - | -141.76 Thousand | -989.38 Thousand | 531.04 Thousand | - |
| Other working capital | 635.51 Thousand | -3.05 Million | -18.51 Million | 19.48 Million | 4.59 Million | -2.43 Million |
| Cash at beginning of period | 44.86 Million | 189.72 Million | 72.03 Million | 41.89 Million | 36.48 Million | 87.12 Million |
| Cash at end of period | 27.04 Million | 46.79 Million | 189.72 Million | 72.03 Million | 41.89 Million | 36.48 Million |
| Capital Expenditure | -137.45 Thousand | -1.41 Million | -189.4 Thousand | -390.68 Thousand | -244.04 Thousand | -352.01 Thousand |
| Effect of forex changes on cash | -17.8 Billion | - | - | - | - | - |
| Net cash flow / Change in cash | -17.82 Million | -142.92 Million | 117.69 Million | 30.13 Million | 5.4 Million | -50.63 Million |
| Free Cash Flow | -45.91 Million | -56.64 Million | 118.42 Million | -51.97 Million | -51.33 Million | -45.91 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.52 Million | -11.69 Million | -52.33 Million | -15.32 Million | -11.25 Million | -12.4 Million |
| Depreciation & Amortization | 148 Thousand | 136 Thousand | 1.59 Million | 401.39 Thousand | 402.46 Thousand | 394.76 Thousand |
| Deferred income taxes | - | - | -1.75 Billion | -105.4 Thousand | 346.34 Thousand | -488.09 Thousand |
| Stock-based compensation | 1.74 Million | 1.96 Million | 7.28 Million | 1.78 Million | 1.63 Million | 1.94 Million |
| Change in working capital | 4.18 Million | -1.74 Million | 2.38 Million | 3.65 Million | 28.98 Thousand | -1.02 Million |
| Other non-cash items | -27.94 Million | -3 Million | 1.74 Billion | -2.32 Million | -1.2 Million | -125.48 Thousand |
| Investing Cash Flow | 12.82 Million | 20.18 Million | -2.58 Million | -48.51 Million | -4.35 Million | 20.06 Million |
| Investments in PPE | -34 Thousand | -19 Thousand | -137.45 Thousand | -1216.00 | -5245.00 | -117.43 Thousand |
| Acquisitions | - | - | -10 Million | 48.5 Million | 4.35 Million | 109.63 Thousand |
| Investment purchases | -37.02 Million | -9.79 Million | -122.44 Million | -58.51 Million | -29.35 Million | -14.81 Million |
| Sales/Maturities of investments | 50 Million | 30 Million | 120 Million | 10 Million | 25 Million | 45 Million |
| Other Investing Activities | 12.85 Million | 20.2 Million | 10 Million | -48.5 Million | -4.35 Million | -10.1 Million |
| Financing Cash Flow | 356 Thousand | 228 Thousand | 30.53 Million | 30.03 Million | 223.71 Thousand | 211.09 Thousand |
| Debt repayment | - | - | -30 Million | -30 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -15.44 Billion | - | - |
| Common Stock Issuance | 356 Thousand | 228 Thousand | 535.2 Thousand | 33.39 Thousand | 223.71 Thousand | 211.09 Thousand |
| Other Financing Activities | 356 Thousand | 228 Thousand | 30 Million | 30.03 Million | 223.71 Thousand | 211.09 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.12 Million | -107 Thousand | 1.75 Million | 2.48 Million | -2.54 Million | 1.93 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.06 Million | -1.63 Million | 635.51 Thousand | 1.16 Million | 2.57 Million | -2.95 Million |
| Cash at beginning of period | 30.77 Million | 27.04 Million | 44.86 Million | 57.43 Million | 73.55 Million | 64.98 Million |
| Cash at end of period | 29.69 Million | 30.77 Million | 27.04 Million | 27.04 Million | 59.36 Million | 73.55 Million |
| Capital Expenditure | -34 Thousand | -19 Thousand | -137.45 Thousand | -1216.00 | -5245.00 | -117.43 Thousand |
| Effect of forex changes on cash | - | - | -17.8 Billion | -15.44 Billion | - | 15.44 Billion |
| Net cash flow / Change in cash | -1.07 Million | 3.73 Million | -17.82 Million | -30.39 Million | -14.18 Million | 8.57 Million |
| Free Cash Flow | -14.28 Million | -16.7 Million | -45.91 Million | -11.91 Million | -10.05 Million | -11.82 Million |
STCN
NWE
FINOPB
TMHC
TIPT
SECCF